人工智能血流与灌注成像正电子发射断层扫描注册研究(REFINE PET):依据与设计
REFINE-PET是一项多中心国际注册研究,收集多中心PET及相关CT图像、临床数据与结局,用QPET软件处理PET、深度学习处理CT检测冠状动脉钙化,随访主要不良心血管事件,目前含14个中心35595例患者数据,旨在验证和发展标准及新型心脏PET/CT处理方法。
要点
- REFINE-PET为多中心国际注册研究,目前含14个中心35595例患者数据
- 随访中位4.2年期间共9278例主要不良心血管事件
- 5955例患者在PET心肌灌注成像后6个月内接受了有创血管造影
核心结论
- REFINE-PET注册研究整合临床、多模态影像及新型定量与人工智能工具,以推进PET/CT心肌灌注成像在诊断和风险分层中的作用。
研究设计与样本
- REFINE-PET为多中心、国际注册研究,包含临床与影像数据。
- PET扫描使用QPET软件(Cedars-Sinai Medical Center,Los Angeles,CA)处理,CT扫描使用深度学习检测冠状动脉钙化。
- 随访主要不良心血管事件,包括死亡、心肌梗死、不稳定型心绞痛和晚期血运重建(距PET超过90天)。
主要发现
- REFINE-PET注册研究目前包含来自14个中心的35595例患者数据,预计还将增加更多患者数据和中心。
- 综合临床数据(包括人口学、病史和负荷试验结果)与34个类别中超过2100个影像变量整合。
- 5955例患者在PET心肌灌注成像后6个月内接受了有创血管造影,中位随访4.2年期间共9278例主要不良心血管事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The REgistry of Flow and Perfusion Imaging for Artificial Intelligence with positron emission tomography (REFINE PET) was established to collect multicenter PET and associated computed tomography (CT) images, together with clinical data and outcomes, into a comprehensive research resource. REFINE-PET will enable validation and development of both standard and novel cardiac PET/CT processing methods. METHODS: REFINE-PET is a multicenter, international registry that contains both clinical and imaging data. The PET scans were processed using QPET software (Cedars-Sinai Medical Center, Los Angeles, CA), while the CT scans were processed using deep learning (DL) to detect coronary artery calcium (CAC). Patients were followed up for the occurrence of major adverse cardiovascular events (MACE), which include death, myocardial infarction, unstable angina, and late revascularization (>90 days from PET). RESULTS: The REFINE-PET registry currently contains data for 35595 patients from 14 sites, with additional patient data and sites anticipated. Comprehensive clinical data (including demographics, medical history, and stress test results) were integrated with more than 2100 imaging variables across 34 categories. The registry is poised to address a broad range of clinical questions, supported by correlating invasive angiography (within 6 months of PET myocardial perfusion imaging [MPI]) in 5955 patients and a total of 9278 major adverse cardiovascular events during a median follow-up of 4.2 years. CONCLUSIONS: The REFINE-PET registry leverages the integration of clinical, multimodality imaging, and novel quantitative and AI tools to advance the role of PET/CT MPI in diagnosis and risk stratification.
引用
- Ramirez G, Lemley M, Shanbhag A, et al. The REgistry of Flow and Perfusion Imaging for Artificial Intelligence with positron emission tomography (REFINE PET):Rationale and design. J Nucl Cardiol. 2025. PMID: 40774620. doi:10.1016/j.nuclcard.2025.102449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。